Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

J Weigel

Showing results (341-350 of 423) with videos related to

Pageof 43
Sort By:
Blood|March 10, 2011
Coexpression of Tim-3 and PD-1 identifies a CD8+ T-cell exhaustion phenotype in mice with disseminated acute myelogenous leukemiaQing Zhou, Meghan E Munger, Rachelle G Veenstra, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|February 15, 2014
Inhibition of RET increases the efficacy of antiestrogen and is a novel treatment strategy for luminal breast cancerPhilip M Spanheimer, Jung-Min Park, Ryan W Askeland, et al.
The Lancet. Oncology|March 21, 2020
Nivolumab in children and young adults with relapsed or refractory solid tumours or lymphoma (ADVL1412): a multicentre, open-label, single-arm, phase 1-2 trialKara L Davis, Elizabeth Fox, Melinda S Merchant, et al.
Annals of Surgical Oncology|October 19, 2014
A novel animal model for locally advanced breast cancerMaria V Bogachek, Jung Min Park, James P De Andrade, et al.
JTCVS Open|May 4, 2026
Surgical nodal sampling established by Commission on Cancer Standard 5.8 is essential for accurate lung cancer stagingRaheem Bell, Amanda B Francescatti, Daniel Boffa, et al.
Cancer Chemotherapy and Pharmacology|October 23, 2020
Safety, tolerability and pharmacokinetics of crizotinib in combination with cytotoxic chemotherapy for pediatric patients with refractory solid tumors or anaplastic large cell lymphoma (ALCL): a Children's Oncology Group phase 1 consortium study (ADVL1212)Emily Greengard, Yael P Mosse, Xiaowei Liu, et al.
The Lancet. Oncology|August 21, 2018
Brentuximab vedotin with gemcitabine for paediatric and young adult patients with relapsed or refractory Hodgkin's lymphoma (AHOD1221): a Children's Oncology Group, multicentre single-arm, phase 1-2 trialPeter D Cole, Kathleen M McCarten, Qinglin Pei, et al.
Pediatric Blood & Cancer|March 23, 2024
A phase 1/2 study of pepinemab in children, adolescents, or young adults with recurrent or refractory solid tumors: A children's oncology group consortium report (ADVL1614)Emily Greengard, Robin Williams, Branden Moriarity, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|July 17, 2013
Phase I pharmacokinetic and pharmacodynamic study of pazopanib in children with soft tissue sarcoma and other refractory solid tumors: a children's oncology group phase I consortium reportJulia L Glade Bender, Alice Lee, Joel M Reid, et al.
Neuro-Oncology Advances|June 23, 2022
Wee1 kinase inhibitor adavosertib with radiation in newly diagnosed diffuse intrinsic pontine glioma: A Children's Oncology Group phase I consortium studySabine Mueller, Tabitha Cooney, Xiaodong Yang, et al.
Pageof 43

Showing results (341-350 of 423) with videos related to

Sort By:
Pageof 43
Blood|March 10, 2011
Coexpression of Tim-3 and PD-1 identifies a CD8+ T-cell exhaustion phenotype in mice with disseminated acute myelogenous leukemiaQing Zhou, Meghan E Munger, Rachelle G Veenstra, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|February 15, 2014
Inhibition of RET increases the efficacy of antiestrogen and is a novel treatment strategy for luminal breast cancerPhilip M Spanheimer, Jung-Min Park, Ryan W Askeland, et al.
The Lancet. Oncology|March 21, 2020
Nivolumab in children and young adults with relapsed or refractory solid tumours or lymphoma (ADVL1412): a multicentre, open-label, single-arm, phase 1-2 trialKara L Davis, Elizabeth Fox, Melinda S Merchant, et al.
Annals of Surgical Oncology|October 19, 2014
A novel animal model for locally advanced breast cancerMaria V Bogachek, Jung Min Park, James P De Andrade, et al.
JTCVS Open|May 4, 2026
Surgical nodal sampling established by Commission on Cancer Standard 5.8 is essential for accurate lung cancer stagingRaheem Bell, Amanda B Francescatti, Daniel Boffa, et al.
Cancer Chemotherapy and Pharmacology|October 23, 2020
Safety, tolerability and pharmacokinetics of crizotinib in combination with cytotoxic chemotherapy for pediatric patients with refractory solid tumors or anaplastic large cell lymphoma (ALCL): a Children's Oncology Group phase 1 consortium study (ADVL1212)Emily Greengard, Yael P Mosse, Xiaowei Liu, et al.
The Lancet. Oncology|August 21, 2018
Brentuximab vedotin with gemcitabine for paediatric and young adult patients with relapsed or refractory Hodgkin's lymphoma (AHOD1221): a Children's Oncology Group, multicentre single-arm, phase 1-2 trialPeter D Cole, Kathleen M McCarten, Qinglin Pei, et al.
Pediatric Blood & Cancer|March 23, 2024
A phase 1/2 study of pepinemab in children, adolescents, or young adults with recurrent or refractory solid tumors: A children's oncology group consortium report (ADVL1614)Emily Greengard, Robin Williams, Branden Moriarity, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|July 17, 2013
Phase I pharmacokinetic and pharmacodynamic study of pazopanib in children with soft tissue sarcoma and other refractory solid tumors: a children's oncology group phase I consortium reportJulia L Glade Bender, Alice Lee, Joel M Reid, et al.
Neuro-Oncology Advances|June 23, 2022
Wee1 kinase inhibitor adavosertib with radiation in newly diagnosed diffuse intrinsic pontine glioma: A Children's Oncology Group phase I consortium studySabine Mueller, Tabitha Cooney, Xiaodong Yang, et al.
Pageof 43